易善复联合甘草酸二铵治疗慢性乙型病毒性肝炎的疗效分析
|
摘要
目的探讨易善复联合甘草酸二铵治疗慢性乙型病毒性肝炎的疗效。方法选取我院2016年1月至2018年7月收治的64例慢性乙型病毒性肝炎患者,随机分为两组各32例。对照组给予甘草酸二铵治疗,观察组给予甘草酸二铵联合易善复治疗,比较两组的治疗效果。结果治疗后,观察组的总有效率、肝功能指标、乙肝症状改善时间、生化指标改善时间、生活质量评分均显著优于对照组,差异有统计学意义(P <0.05)。两组的治疗不良反应发生率无统计学差异(P>0.05)。结论甘草酸二铵联合易善复治疗慢性乙型病毒性肝炎的疗效确切。
Objective To explore the efficacy of Yishanfu combined with diammonium glycyrrhizinate in the treatment of chronic viral hepatitis B. Methods A total of 64 patients with chronic viral hepatitis B admitted to our hospital from January 2016 to July 2018 were selected and randomly divided into two groups, with 32 cases in each group. The control group was treated with diammonium glycyrrhizinate,and the observation group was treated with diammonium glycyrrhizinate combined with Yishanfu. The curative effects of two groups were compared. Results After treatment, the total effective rate, liver function indicators, improvement time of hepatitis B symptom, improvement time of biochemical indicator, and quality of life scores of the observation group were significantly better than those of the control group(P<0.05). Conclusions Yishanfu combined with diammonium glycyrrhizinate in the treatment of chronic viral hepatitis B has exact efficacy.
Objective To explore the efficacy of Yishanfu combined with diammonium glycyrrhizinate in the treatment of chronic viral hepatitis B. Methods A total of 64 patients with chronic viral hepatitis B admitted to our hospital from January 2016 to July 2018 were selected and randomly divided into two groups, with 32 cases in each group. The control group was treated with diammonium glycyrrhizinate,and the observation group was treated with diammonium glycyrrhizinate combined with Yishanfu. The curative effects of two groups were compared. Results After treatment, the total effective rate, liver function indicators, improvement time of hepatitis B symptom, improvement time of biochemical indicator, and quality of life scores of the observation group were significantly better than those of the control group(P<0.05). Conclusions Yishanfu combined with diammonium glycyrrhizinate in the treatment of chronic viral hepatitis B has exact efficacy.
引文
[1]王晓慧.慢性乙型肝炎、乙肝后肝硬化中医病理特征及其与肝纤维化指标的关系研究[D].福州:福建中医药大学, 2017.
[2]冯硕.中药治疗慢性乙肝病毒携带者、肝纤维化和肝硬化的系统评价及结论偏倚方法学研究[D].北京:北京中医药大学, 2017.
[3]贾云飞.慢乙肝发生肝癌风险预测模型的建立及中西医结合治疗对乙肝肝硬化患者肝癌发病的影响[D].北京:北京中医药大学, 2017.
[4]栾庆鑫.益气解毒通络方治疗乙肝肝硬化有效性及其控制癌变的回顾性研究[D].北京:北京中医药大学, 2017.
[5]刘皓怡.慢乙肝患者述情障碍与中医体质的调查研究[D].广州:广州中医药大学, 2017.
[6]杨铂.基于中医传承辅助系统的慢性乙型肝炎活血化瘀方药研究[D].济南:山东中医药大学, 2016.
[7]冯因克,刘亚敏,陈启龙.慢性乙型肝炎后肝硬化中西医治疗研究进展[J].中国医药导报, 2016, 13(29):28-31.
[8]刘亚敏,石玉琳,陈健,等.慢性乙型肝炎后肝硬化证候的生物物质基础研究进展[J].世界科学技术:中医药现代化, 2016, 18(9):1493-1499.
[2]冯硕.中药治疗慢性乙肝病毒携带者、肝纤维化和肝硬化的系统评价及结论偏倚方法学研究[D].北京:北京中医药大学, 2017.
[3]贾云飞.慢乙肝发生肝癌风险预测模型的建立及中西医结合治疗对乙肝肝硬化患者肝癌发病的影响[D].北京:北京中医药大学, 2017.
[4]栾庆鑫.益气解毒通络方治疗乙肝肝硬化有效性及其控制癌变的回顾性研究[D].北京:北京中医药大学, 2017.
[5]刘皓怡.慢乙肝患者述情障碍与中医体质的调查研究[D].广州:广州中医药大学, 2017.
[6]杨铂.基于中医传承辅助系统的慢性乙型肝炎活血化瘀方药研究[D].济南:山东中医药大学, 2016.
[7]冯因克,刘亚敏,陈启龙.慢性乙型肝炎后肝硬化中西医治疗研究进展[J].中国医药导报, 2016, 13(29):28-31.
[8]刘亚敏,石玉琳,陈健,等.慢性乙型肝炎后肝硬化证候的生物物质基础研究进展[J].世界科学技术:中医药现代化, 2016, 18(9):1493-1499.